Search

Search Constraints

You searched for: Author/Creator Malik, Fady I.

Search Results

1. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Issue 3 (3rd April 2021)

2. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Issue 7 (2nd October 2019)

3. Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial. (December 2020)

5. Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF. (3rd March 2022)

6. Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study. (December 2020)

7. Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. (16th January 2023)

8. Fast skeletal muscle troponin activator CK‐2066260 increases fatigue resistance by reducing the energetic cost of muscle contraction. (17th July 2019)